JNJ

Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says
Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says
CNBC
JNJ
vaccines
COVID-19
Flag link:
The top 10 largest biopharma M&A deals in 2020
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Flag link:
J&J’s Darzalex Faspro is first US therapy for rare blood disorder
J&J’s Darzalex Faspro is first US therapy for rare blood disorder
Pharmaforum
JNJ
Darzalex Faspro
FDA
light chain amyloidosis
Flag link:
10 key clinical trials to watch in the first half of 2021
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Flag link:
J&J single-shot COVID-19 vaccine shows early promise
J&J single-shot COVID-19 vaccine shows early promise
Pharmaforum
JNJ
COVID-19
vaccines
clinical trials
Flag link:
Intuitive, J&J, Medtronic and Zimmer talk robotic surgery ambitions: JPM21
Intuitive, J&J, Medtronic and Zimmer talk robotic surgery ambitions: JPM21
Medtech Dive
JPMHC 2021
robotic surgery
devices
Intuitive Surgical
JNJ
Medtronic
Zimmer Biomet
Flag link:
Johnson & Johnson Expects Vaccine Results Soon but Lags in Production
Johnson & Johnson Expects Vaccine Results Soon but Lags in Production
NY Times, NY
COVID-19
JNJ
vaccines
manufacturing
Flag link:
Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up
Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up
Stat
JNJ
vaccines
COVID-19
clinical trials
Flag link:
COVID-19 in the ER? Level Ex uses J&J grant to simulate infections in medical education video games
COVID-19 in the ER? Level Ex uses J&J grant to simulate infections in medical education video games
Fierce Pharma
JNJ
Level Ex
video games
pandemic
COVID-19
Flag link:
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
Fierce Pharma
JNJ
JPMHC 2021
vaccines
COVID-19
clinical trials
Flag link:
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
Motley Fool
JNJ
vaccines
COVID-19
Ad26.COV2-S
clinical trials
Flag link:
Astrazeneca shows megamergers were still possible in 2020
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Flag link:
Medtronic, J&J and Edwards among medtechs to headline at JP Morgan
Medtronic, J&J and Edwards among medtechs to headline at JP Morgan
Medtech Dive
devices
Medtech
JPMHC 2021
Medtronic
JNJ
Edwards
Flag link:
Corporate and regulatory developments over the holidays
Corporate and regulatory developments over the holidays
EP Vantage
AstraZeneca
Bristol-Myers Squibb
Celltrion
Cullinan Oncology
JNJ
Myovant Sciences
Osmotica Pharmaceuticals
Pfizer
Y-mAbs Therapeutics
United Therapeutics
Zai Lab
Flag link:
10 Biopharma Stories to Look Forward to in 2021
10 Biopharma Stories to Look Forward to in 2021
BioSpace
pandemic
COVID-19
vaccines
Joe Biden
drug pricing
M&A
venture capital
JNJ
Biomarin
Bluebird Bio
TG Therapeutics
Biogen
AstraZeneca
Flag link:
Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA
Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA
Pharmaforum
JNJ
Janssen
Multiple Myeloma
CAR-T
cilta-cel
FDA
Bristol-Myers Squibb
ide-cel
Flag link:
The top 5 pharma M&A deals of 2020
The top 5 pharma M&A deals of 2020
Pharmaforum
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
Flag link:
Best-selling Tagrisso further outpaces an upcoming J&J rival, winning approval in new NSCLC indication
Best-selling Tagrisso further outpaces an upcoming J&J rival, winning approval in new NSCLC indication
Endpoints
AstraZeneca
Tagrisso
non-small cell lung cancer
JNJ
amivantamab
Flag link:
2 COVID Vaccine Stocks With Key Results on the Way
2 COVID Vaccine Stocks With Key Results on the Way
Motley Fool
vaccines
COVID-19
JNJ
AstraZeneca
Flag link:
Former J&J VP sues pharma giant, accusing top execs of discriminating, harassing and retaliating against her
Former J&J VP sues pharma giant, accusing top execs of discriminating, harassing and retaliating against her
Endpoints
JNJ
R&D
gender discrimination
Flag link:

Pages